Junchao Tong Selected Research

Methamphetamine (Desoxyn)

1/2022	Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker study.
1/2017	Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.
3/2016	Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.
7/2014	Is brain gliosis a characteristic of chronic methamphetamine use in the human?
6/2010	Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junchao Tong Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2004
6	Gliosis 01/2022 - 07/2014
6	Multiple System Atrophy 01/2020 - 01/2004
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 01/2004
4	Neoplasms (Cancer) 09/2023 - 05/2021
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 01/2021
4	Substance-Related Disorders (Drug Abuse) 09/2020 - 01/2016
3	Neuroinflammatory Diseases 12/2022 - 04/2021
3	Dyskinesias (Dyskinesia) 01/2016 - 01/2004
2	Lewy Body Disease (Lewy Body Dementia) 02/2024 - 01/2010
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2023 - 03/2016
2	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 08/2021
2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2020 - 07/2014
2	Alcoholism (Alcohol Abuse) 01/2020 - 01/2018
2	Cocaine-Related Disorders (Cocaine Addiction) 01/2018 - 01/2014
2	Parkinsonian Disorders (Parkinsonism) 09/2017 - 01/2010
2	Cognitive Dysfunction 03/2016 - 01/2008
1	Multiple Sclerosis 09/2023
1	Infections 09/2023
1	Rodent Diseases 09/2023
1	Autoimmune Diseases (Autoimmune Disease) 09/2023
1	Arthritis (Polyarthritis) 09/2023
1	Amyloid Plaque 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Diffuse Intrinsic Pontine Glioma 05/2021
1	Narcolepsy 01/2021
1	Mental Disorders (Mental Disorder) 01/2020
1	Obesity 01/2020
1	Schizophrenia (Dementia Praecox) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Heroin Dependence (Heroin Abuse) 01/2018
1	Mood Disorders (Mood Disorder) 01/2017
1	Marijuana Abuse (Cannabis Abuse) 11/2016
1	Dizziness (Lightheadedness) 01/2016
1	Anxiety Disorders (Anxiety Disorder) 08/2015
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 02/2015

Drug/Important Bio-Agent (IBA)

13	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2010
7	EndocannabinoidsIBA 09/2023 - 08/2015
7	EnzymesIBA 01/2021 - 08/2015
5	Monoamine Oxidase (MAO)IBA 01/2022 - 01/2017
5	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 06/2010
5	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 05/2009
5	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 01/2008
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2021 - 08/2015
3	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2017
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 12/2006
3	naxagolideIBA 01/2016 - 05/2009
3	Levodopa (L Dopa)FDA LinkGeneric 01/2016 - 01/2004
2	SynucleinsIBA 02/2024 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2021
2	AntioxidantsIBA 01/2023 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 07/2014
2	RacloprideIBA 01/2021 - 05/2009
2	Dopamine D3 ReceptorsIBA 01/2019 - 01/2016
1	evobrutinibIBA 09/2023
1	LipopolysaccharidesIBA 09/2023
1	PalladiumIBA 09/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 09/2023
1	N 30IBA 01/2023
1	Serum Amyloid P-ComponentIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2023
1	FructoseIBA 12/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	SL25.1188IBA 01/2022
1	Cyclooxygenase 1IBA 10/2021
1	Ketoprofen (Orudis)FDA LinkGeneric 10/2021
1	11C-PS13IBA 10/2021
1	Glycogen Synthase Kinase 3IBA 08/2021
1	Glycogen Synthase (Synthase I)IBA 08/2021
1	Activin Receptors (Activin Receptor)IBA 05/2021
1	dipinacoline glutamateIBA 05/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 09/2020
1	CannabinoidsIBA 01/2019
1	Cocaine (Cocaine HCl)IBA 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 09/2017
1	Oxidoreductases (Dehydrogenase)IBA 09/2017
1	GlucocorticoidsIBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	anandamide (arachidonylethanolamide)IBA 11/2016
1	dihydrotetrabenazineIBA 03/2016
1	Buspirone (Buspar)FDA LinkGeneric 01/2016
1	Dopamine Agonists (Dopamine Agonist)IBA 02/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2014
1	HLA-DR Antigens (HLA-DR)IBA 07/2014

Therapy/Procedure

2	Therapeutics 10/2015 - 05/2009